Mirum Pharmaceuticals Inc...

NASDAQ: MIRM · Real-Time Price · USD
67.89
3.06 (4.72%)
At close: Aug 15, 2025, 3:59 PM
67.86
-0.04%
After-hours: Aug 15, 2025, 06:59 PM EDT

Mirum Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.86M -14.68M -23.79M -14.23M -24.64M -25.28M -33.15M -23.59M -74.04M -30.13M -36.43M -35.71M -26.92M -36.61M 57.55M -47.11M -43.89M -50.53M
Depreciation & Amortization
6.06M 6.05M 6.06M 6.05M 5.85M 5.66M 5.4M 2.66M 1.19M 1.48M 1.33M 1.2M 705K 443K 437K 178K 175K 185K
Stock-Based Compensation
18.47M 15.8M 13.25M 11.91M 11.84M 11.45M 9.72M 8.38M 8.36M 8.56M 6.9M 6.73M 6.82M 6.56M 5.56M 7.42M 4.82M 5.29M
Other Working Capital
3.53M -3.53M 57K -17.73M 1.14M 660K -1.07M -2.98M -1.02M 17.66M -1.89M -3.5M 1.93M -1.05M -2.57M -2.72M 49K -429K
Other Non-Cash Items
-17.92M 2.16M 1.1M 9.67M 3.94M 932K 42.59M 601K 50.63M 3.94M 9.47M 3.56M 2.29M 3.73M -104.23M 5.67M 4.78M 3.38M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -30.31M -638K 32K n/a -6.58M n/a -6.58M n/a 1.09M -1.41M 1.24M -328K
Change in Working Capital
11.3M -11.3M -1.68M -9.42M -794K 21.73M -10.87M -5.64M 11.5M -17.63M -8.96M -1.82M 3.52M -13.8M 6.45M 1.06M -7.32M 16.8M
Operating Cash Flow
12.04M -1.96M -5.07M 3.98M -3.8M 15.21M -16.62M -18.22M -2.33M -33.77M -34.27M -26.02M -20.17M -39.67M -33.15M -34.2M -40.2M -25.21M
Capital Expenditures
-126K -41K -20K -10.18M -10.78M -13K -5M n/a -15.07M -41K -242K -19K -17K n/a -19M -18K n/a -3K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 239.82M -212.76M 15M -42.06M n/a 79.51M -23.99M n/a -19M n/a n/a -2M
Purchase of Investments
-31.54M -33.53M -11.48M -15.61M -61.94M n/a n/a n/a -4.88M -22.44M n/a -117.51M -14.81M n/a -18.97M -49.72M -45.95M -83.38M
Sales Maturities Of Investments
25.06M 17.43M 12.14M 7.75M n/a n/a 3M 30M 55.5M 64.5M 27M 38M 38.8M 36.5M 38M 47.5M 21.5M 50.6M
Other Investing Acitivies
n/a n/a n/a -10M -10M n/a -2M 30M -15M 42.06M 27M -79.51M 23.99M 36.5M 127M -2.22M -24.45M 2M
Investing Cash Flow
-6.6M -16.13M 641K -18.04M -72.72M -13K -2M -182.76M 35.55M 42.02M 26.76M -79.53M 23.97M 36.5M 108.02M -2.24M -24.45M -32.78M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.03M -1.67M n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-6.36M 6.36M 5.34M 3.86M 7.29M 1.21M 1.94M 4.77M 114.71M -1.49M 1.98M 1.38M 1.34M 720K -120K 345K 65.91M -320K
Financial Cash Flow
8.69M 6.36M 5.34M 3.86M 7.29M 1.21M 1.78M 207.13M 114.71M 12.99M -329K 86.07M 5.25M 18.1M 615K 345K 65.91M 6.59M
Net Cash Flow
16.36M -10.68M -466K -9.85M -69.35M 16.52M -16.73M 5.83M 147.81M 21.42M -7.76M -19.51M 9M 14.93M 75.5M -36.09M 1.26M -51.41M
Free Cash Flow
11.91M -2M -5.09M -6.2M -14.58M 15.2M -21.62M -18.22M -17.4M -33.81M -34.51M -26.04M -20.19M -39.67M -52.15M -34.22M -40.2M -25.21M